KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer
Translational Lung Cancer Research · 2023-08 · 12 (8) · 1830-1833
DOI: 10.21037/tlcr-23-271 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Lung Cancer Research, 2023-08. Verfasst von Hao Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chemotherapy Center, Yokohama Minami Kyosai Hospital, Yokohama, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chemotherapy Center, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
- Department of Respiratory, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
- Chemotherapy Center, Yokohama City University Hospital, Yokohama, Japan.
- Department of Pulmonology, Yokohama City University, Yokohama, Japan.
Zitieren
APA
Chen, H., Yumoto, K., Kashizaki, F., Koizumi, H., Ikeda, I., Horita, N., Takahashi, K., & Kaneko, T. (2023). KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer. Translational Lung Cancer Research, 12(8), 1830-1833. https://doi.org/10.21037/tlcr-23-271
Vancouver
Chen H, Yumoto K, Kashizaki F, Koizumi H, Ikeda I, Horita N, et al. KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer. Translational Lung Cancer Research. 2023;12(8):1830-1833. doi:10.21037/tlcr-23-271
BibTeX
@article{Chen2023,
author = {Chen, Hao and Yumoto, Kentaro and Kashizaki, Fumihiro and Koizumi, Harumi and Ikeda, Ichiro and Horita, Nobuyuki and Takahashi, Kenichi and Kaneko, Takeshi},
title = {KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
year = {2023},
volume = {12},
number = {8},
pages = {1830--1833},
doi = {10.21037/tlcr-23-271}
}
EUVIMED